Summary of Significant Accounting Policies (Tables)

3 Months Ended

Sep. 30, 2024

Accounting Policies [Abstract]

Schedule of Net Revenue Disaggregated by Product and Region

The following table summarizes our net revenue disaggregated by segment, product and region (in thousands):

	Three Months Ended September 30,
	2024		2023
U.S., Canada and Latin America
Devices	$	384,530	$	345,897
Masks and other	322,776		292,461
Total U.S., Canada and Latin America	$	707,306	$	638,358
Combined Europe, Asia and other markets
Devices	$	241,255	$	218,831
Masks and other	119,176		105,848
Total Combined Europe, Asia and other markets	$	360,431	$	324,679
Global revenue
Total Devices	$	625,785	$	564,728
Total Masks and other	441,952		398,309
Total Sleep and Breathing Health	$	1,067,737	$	963,037
Residential Care Software	156,772		139,284
Total	$	1,224,509	$	1,102,321

Schedule of Contract Balances

The following table summarizes our contract balances (in thousands):

	September 30, 2024		June 30, 2024		Balance sheet caption
Contract assets
Accounts receivable, net	$	811,198	$	837,275	Accounts receivable, net
Unbilled revenue, current	43,829		38,183		Prepaid expenses and other current assets
Unbilled revenue, non-current	15,855		18,450		Prepaid taxes and other non-current assets
Contract liabilities
Deferred revenue, current	(157,188)		(152,554)		Deferred revenue (current liabilities)
Deferred revenue, non-current	(144,453)		(137,343)		Deferred revenue (non-current liabilities)